![](/img/cover-not-exists.png)
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial
Roblin, X., Boschetti, G., Williet, N., Nancey, S., Marotte, H., Berger, A., Phelip, J. M., Peyrin-Biroulet, L., Colombel, J. F., Del Tedesco, E., Paul, S., Flourie, B.Language:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.14106
Date:
April, 2017
File:
PDF, 550 KB
english, 2017